Albumin-bound Paclitaxel (Ab-Pac) Versus Docetaxel for First-Line Treatment of Metastatic Breast Cancer (MBC): Final Overall Survival (OS) Analysis of a Randomized Phase II Trial.

W. J. Gradishar,D. Krasnojon,S. V. Cheporov,A. Makhson,G. M. Manikhas,A. Clawson,P. Bhar

Journal of clinical oncology（2011）

引用 7|浏览26

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要